Stephen Uden
Founder bij RALLYBIO CORPORATION
Vermogen: 1 M $ op 31-03-2024
Profiel
Stephen Uden is the founder.
He founded Rallybio LLC in 2018 and currently holds the title of Chief Operating Officer.
He also founded Rallybio Corp.
in 2018 and currently holds the titles of President, Chief Executive Officer & Director.
Dr. Uden's former job includes being the Head of Research & Development at Neurogen Corp.
and Senior Vice President of Research at Alexion Pharmaceuticals, Inc. Dr. Uden's education includes an undergraduate degree from the University of London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RALLYBIO CORPORATION
1.90% | 31-03-2024 | 719 127 ( 1.90% ) | 1 M $ | 31-03-2024 |
Actieve functies van Stephen Uden
| Bedrijven | Functie | Begin |
|---|---|---|
| RALLYBIO CORPORATION | Founder | 01-01-2018 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Founder | 01-01-2018 |
Eerdere bekende functies van Stephen Uden
| Bedrijven | Functie | Einde |
|---|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 14-09-2007 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Stephen Uden
| University of London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
